Target intelligence / Profile preview

Microglial-mediated clearance of aggregated tau

Molecular classification
Cellular Process, Immune cell function
01

Overview

Microglial-mediated clearance of aggregated tau refers to the process by which microglia recognize, internalize, and degrade pathological forms of tau protein. Microglia can internalize both monomeric and fibrillar forms of extracellular tau through phagocytosis. The efficiency with which microglia clear tau aggregates depends on several factors, including the phosphorylation state of tau, receptor interactions (CX3CR1, TLRs), and lysosomal function. In AD, microglia play a dual role: protective by engulfing and degrading extracellular aggregated tau, and pathogenic by releasing exosomes containing seeding-competent tau species. Genetic variants affecting microglial function—such as those in TREM2—are associated with altered risk for AD. Experimental manipulation enhancing microglial phagocytic activity has been shown to reduce amyloid plaque load; similar strategies are being explored for promoting clearance of pathological tau species.

Other names
Microglial tau clearanceTau phagocytosis by microgliaMicroglia-mediated tau degradation
02

Mechanism of action

Enhancing microglial phagocytic activity to promote clearance of pathological tau species

03

Biological functions

PhagocytosisLysosomal degradationImmune responseProtein clearanceExosome release (in pathological context)
04

Disease associations

Alzheimer's diseaseTauopathiesNeurodegenerative disease
05

Safety considerations

Potential for microglia to exacerbate tau pathology through exosome-mediated release of seeding-competent tauOff-target effects of microglial activationInflammatory response associated with microglial activation
06

Biomarkers

TREM2 variantsPhosphorylation state of TauCytokine milieuMicroglial activation state

Beyond the preview

Go deeper on Microglial-mediated clearance of aggregated tau.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microglial-mediated clearance of aggregated tau.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call